DDMAC asks companies to notify FDA if they participate in DTC program

Share this article:
DDMAC asked companies to notify FDA within 30 days if they intend to participate in the DTC user fee program in 2008 and to identify the number of DTC TV ads they plan to submit for advisory review—with the caveat that if FDA does not receive at least $11.2 million in funding for the program within 120 days of the enactment of the FDA Amendments Act, the program will not commence.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?